Zylo Therapeutics is a company that introduces a delivery system which uses patented xerogel-derived silica particles (Z-pod) to deliver notoriously hard-to-deliver therapeutic agents through topical administration. The delivery system is also enhanced druggability.
Zylö Therapeutics total Funding
Zylö Therapeutics latest funding size
Time since last funding
|5 months ago|
Zylö Therapeutics investors
|New York Angels, SC Launch, Boston Harbor Angels, VentureSouth, Ariel Southeast Angel Partners|
When was Zylö Therapeutics founded?
Zylö Therapeutics was founded in 2017.
Who are Zylö Therapeutics key executives?
Zylö Therapeutics's key executives are Scott Pancoast, John Lind and Michael Rabin.
Who are Zylö Therapeutics competitors?
Competitors of Zylö Therapeutics include Rigaku, Direct Flow Medical and ProtoKinetix.
Where is Zylö Therapeutics headquarters?
Zylö Therapeutics headquarters is located at 200 Patewood Dr Building C, Suite 400, Greenville.
Where are Zylö Therapeutics offices?
Zylö Therapeutics has an office in Greenville.
How many offices does Zylö Therapeutics have?
Zylö Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies